Skip to main content
Fig. 6 | European Journal of Medical Research

Fig. 6

From: Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical study

Fig. 6

Correlations between ACBD3 expression and receiver operating characteristic (ROC) curve across TCGA tumors, area under the ROC curve (AUC) value > 0.7 was considered to have a diagnostic value. As a measure of diagnostic accuracy, the value of AUC is closer to 1, the diagnostic value is higher. A cholangiocarcinoma (CHOL) (AUC = 0.990), B liver hepatocellular carcinoma (LIHC) (AUC = 0.863), C stomach adenocarcinoma (STAD) (AUC = 0.902), D pancreatic adenocarcinoma (PAAD) (AUC = 0.756), E esophageal carcinoma (ESCA) (AUC = 0.883), F esophagus adenocarcinoma (ESAD) (AUC = 0.901), G esophagus squamous cell carcinoma (ESCC) (AUC = 0.841), H breast invasive carcinoma (BRCA) (AUC = 0.805), I kidney chromophobe (KICH) (AUC = 0.895), J Lung cancer (LUADLUSC) (AUC = 0.726), K lung squamous cell carcinoma (LUSC) (AUC = 0.717), L lung adenocarcinoma (LUAD) (AUC = 0.741), M sarcoma (SARC) (AUC = 0.930), N pheochromocytoma and paraganglioma (PCPG) (AUC = 0.739), O glioblastoma multiforme (GBM) (AUC = 0.787), P Glioma (GBMLGG) (AUC = 0.708), Q Oral squamous cell carcinoma (OSCC) (AUC = 0.701)

Back to article page